The building of Arena and the discovery and development of BELVIQ


Thu, September 18, 18:00 – 20:00


Arena Pharmaceuticals Inc - 6154 Nancy Ridge Dr - San Diego, CA 92121


For details, click here:

About the speaker: Dr. Behan now serves as Arena’s Executive Vice President and Chief Scientific Officer, was recently included in the PharmaVOICE 100 list of most inspiring people in the life-sciences industry, and received a higher doctorate D.Sc. from the University of Reading for his contributions to the field. Dr. Behan is the author of numerous publications and patents that address multiple therapeutic areas encompassing protein/neuropeptide and small molecule modulation of neuroendocrine, cardiovascular and metabolic systems.

ABOUT THE PRESENTATION: The presentation will review the initial founding of Arena Pharmaceuticals Inc. and focus on the discovery of BELVIQ® (lorcaserin HCl), which was approved by the US FDA for chronic weight management. BELVIQ is the first new chemical entity approved by the FDA in 13 years for obesity and is the first drug approved in the class of selective 5-HT2C agonists. BELVIQ was reviewed by the Prix Galien awards committee and was accepted in July 2013 and July 2014 as a nominee in the Best Pharmaceutical Agent category.